Skip to Content

Tag Archives: Pfizer

February 2008 Issue

“Stop, look and listen!” If you’ve ever seen those words signposted at
a railroad crossing, you know how to handle today’s skittish — and
increasingly erratic — stock market. With anxiety over the economic
outlook spreading on Wall Street, this is a time to weigh your steps
carefully. Buy selectively, yes; but pace yourself, and make sure you’ve got an ample cash reserve to keep you company.

In this month’s visit, I’ll show you how to manage your money cautiously and prudently through this rough patch. We’re enriching our model portfolio with a conservative growth stock that features not only a generous
dividend but also strong prospects for a price gain of 20% or more in
the coming year. At the same time, we’re boosting our cash holdings by a
couple of percentage points to build a warchest for our next big bargainhunting foray, probably sometime in the spring.

Many of the risks in today’s market are still hidden. If you’re retired or nearing retirement, it may surprise you to learn that some of the utility stocks or utility mutual funds you own could be riding for a fall. On p. 3, I’ll name these potential time bombs. Fortunately, there’s an alternative investment at hand that will let you double or even triple your income, with substantially less risk. Switch now!

December 2007 Issue

With the Dow gyrating wildly and the dollar sinking to record lows, is
it time to step up your overseas investments? Well, yes — but not
quite the way most gurus are advising. With a few notable exceptions, foreign stock markets, especially the “emerging” bourses, have skyrocketed in recent years, particularly in dollar terms. For a U.S.-based investor, bargains are getting harder to find.

However, there’s a nifty back-door entry into the arena of global
growth — and the seats are cheap, too. Many of America’s largest and bestmanaged companies earn a hefty chunk of their sales and profits outside our borders. By plugging these stocks into your portfolio, you can ride the global economic boom more safely and efficiently than if you dabbled in
stock markets from Paris to Shanghai.

In this month’s visit, I’ll introduce you to four of these multinational gems, all poised to deliver a total return (dividends plus capital
appreciation) that could stretch as high as 25% – 35% in the coming year.
After the rocky market we’ve had lately, I suspect your nerves are as ready as mine for a big win!

June 2007 Issue

Rodney Dangerfield may be gone, but Wall Street’s “I don’t get no respect” bull market is keeping his legacy alive. Dow at another new all-time high? Shrug. Takeovers spiking stocks left and right? Yawn. We’re in the midst of what ought to be a rollicking party, and most of the guests are half-asleep!
To be honest with you, I’m delighted with this state of affairs. It suggests that the advance will last longer, and climb to far greater heights, than the majority of observers now expect. When this bull is ready to keel over, it will be from too much revelry�not an excess of caution.
In this month’s visit, I’ll show you how to pinpoint the safest, most value-packed stocks in this underappreciated market. Remarkably, some of my top candidates are household names, giants “hidden in plain sight.” I’ve got three for you that could easily pop 20%�30% in the coming year, with even bigger gains down the road.

January 2007 Issue & Supplement

After four good years, can the markets hand us another winner in 2007? The answer is YES! We’re in an exciting phase for the markets and I’m expecting another double-digit year for the major stock indexes, plus 20%-30% (and even bigger) returns for a number of our favorite picks!

In this month’s issue I’ll share with you my roadmap for the New Year, including my insights into some speed bumps we might experience along the way. I’ll let you know one way to remain calm during the inevitable stock market “corrections” and I’ll give you some of my best ideas on how to outwit Dr. Bernanke at his own game.

And later, in this month’s special supplement, I’ll give you Six Pearls of Investment Wisdom, something we all need in order to make the most of our opportunities while keeping our risks low.

January 2007 Issue & Supplement

After four good years, can the markets hand us another winner in 2007? The answer is YES! We’re in an exciting phase for the markets and I’m expecting another double-digit year for the major stock indexes, plus 20%-30% (and even bigger) returns for a number of our favorite picks!
In this month’s issue I’ll share with you my roadmap for the New Year, including my insights into some speed bumps we might experience along the way. I’ll let you know one way to remain calm during the inevitable stock market “corrections” and I’ll give you some of my best ideas on how to outwit Dr. Bernanke at his own game.
And later, in this month’s special supplement, I’ll give you Six Pearls of Investment Wisdom, something we all need in order to make the most of our opportunities while keeping our risks low.

Bitter Pill for Pfizer

Even the best and the brightest can stumble. Need proof? Just chew on the latest news from Pfizer (NYSE: PFE). Over the weekend, PFE announced it was halting development of the most promising drug in its pipeline, torcetrapib. However, I am hopeful but realistic that PFE can regain the offensive and grow its business again within a reasonable time frame.

December 2006 Issue

Gridlock! Whether you’re delighted or dismayed by the results of the midterm election, I’ve got encouraging news for you—a divided government in Washington isn’t such a bad thing for your investments. This month, I’ll show you how you can take advantage of the new paths to profit that the election has opened up. In fact, I expect gains of 40%-60% in the next two years for my top picks. December also marks the fourth anniversary of our Incredible Dividend Machine. This nifty portfolio has beaten the overall stock market by such a huge margin it’s almost amusing. In our latest lineup, I’m swapping two of the members of the Machine with new names that I’m confident will keep the streak going. Finally, the holiday season is the perfect time to do some housecleaning, and if you’re sitting on a mutual fund that has outlived its usefulness, raise a glass of holiday cheer and toast it good-bye. Then replace it with one of my four best funds for your specific needs.

September 2006 Issue & Supplement

Many income investments are already celebrating the Fed’s decision to pause. (Several of our utility stocks lately have bounced up to 52-week
highs.) However, I’m still uncovering juicy yields in some out-of-the-way places. I have compiled a menu of income plays that will deliver you
a generous cash payout of up to 7% annually, with ample scope for capital gains, too.

September 2006 Issue & Supplement

Many income investments are already celebrating the Fed’s decision to pause. (Several of our utility stocks lately have bounced up to 52-week
highs.) However, I’m still uncovering juicy yields in some out-of-the-way places. I have compiled a menu of income plays that will deliver you
a generous cash payout of up to 7% annually, with ample scope for capital gains, too.

August 2006 Issue

In this month’s visit, I’ll show you how to reserve your seat for the ride up. Surprisingly, perhaps, some of tomorrow’s biggest winners
are likely to be stocks that most investors have heard of—but don’t happen to own. I’ll point you to three, in particular, that should
comfortably double your wealth over the next three to five years.